Edges in Network
| Network | GSE12093_top8000 - GSE12093 - SiGN-BN NNSR |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | HAT1 |
| Upstream (Parents) |
|---|
| (<<) RPL10A → HAT1 |
| (<<) FDX1 → HAT1 |
| (<<) ITGB1BP1 → HAT1 |
| (<<) MCTS1 → HAT1 |
| (<<) CHMP5 → HAT1 |
| (<<) WDR61 → HAT1 |
| Downstream (Children) |
|---|
| HAT1 → PARP8 (>>) |
| HAT1 → DYNC1LI1 (>>) |
| HAT1 → ATF1 (>>) |
| HAT1 → PNMA3 (>>) |
| HAT1 → WTAP (>>) |
| HAT1 → CAMSAP1L1 (>>) |
| HAT1 → TFRC (>>) |
| HAT1 → SAMM50 (>>) |
| HAT1 → ZNF131 (>>) |
| HAT1 → TOM1L1 (>>) |
| HAT1 → INSIG2 (>>) |
| HAT1 → FDX1 (>>) |
| HAT1 → DCK (>>) |
| HAT1 → ITGB1BP1 (>>) |
| HAT1 → MOBKL3 (>>) |
| HAT1 → ZNF259P1///ZNF259 (>>) |
| HAT1 → R3HDM1 (>>) |
| HAT1 → MCTS1 (>>) |
| HAT1 → CYBRD1 (>>) |
| HAT1 → CA2 (>>) |
| HAT1 → PRKDC (>>) |
| HAT1 → RPL39L (>>) |
| HAT1 → STAM2 (>>) |
| HAT1 → SLC33A1 (>>) |
| HAT1 → NVL (>>) |
| HAT1 → ITPR1 (>>) |
| HAT1 → MANEA (>>) |
| HAT1 → GRAMD3 (>>) |
| HAT1 → ZNF318 (>>) |
| HAT1 → PDZRN3 (>>) |
| HAT1 → HBS1L (>>) |
| HAT1 → HIGD1A (>>) |
| HAT1 → WDR61 (>>) |
| HAT1 → MED17 (>>) |
| HAT1 → IGSF9B (>>) |
| HAT1 → SNX7 (>>) |
| HAT1 → ANAPC10 (>>) |
| HAT1 → SPAG11A (>>) |
| HAT1 → EMP1 (>>) |
| HAT1 → GNL3LP1 (>>) |
| HAT1 → PRAMEF13///PRAMEF2///PRAMEF1 (>>) |
| HAT1 → CUBN (>>) |
| HAT1 → USP46 (>>) |
| HAT1 → SERPINB8 (>>) |
| HAT1 → HSD17B14 (>>) |
| HAT1 → CHMP2B (>>) |
| HAT1 → DSP (>>) |
| HAT1 → BID (>>) |
| HAT1 → CD9 (>>) |
